文献速递肿瘤 PET/CT放射性药物与辐射防护

全身PET/CT——首批临床经验与未来展望

Total-body PET/CT - First Clinical Experiences and Future Perspectives.
PubMed 文献 · Semin Nucl Med · 2022-03-07

本文综述全身PET及长轴视野(>1m)扫描仪的临床应用经验与前景:信号采集效率与空间分辨率提升可提高敏感性和病灶检出,支持缩短采集时间、降低给药活度、延迟扫描、改善图像质量及全身动态成像;同时带来假阳性增多、延迟扫描流程与判读问题、数据存储与重建时间等挑战。

要点

  • 全身PET/CT可缩短采集时间并保持诊断质量图像,利于儿童等特定临床情形。
  • 可降低给药活度而对图像噪声影响极小,从而降低患者有效剂量并改善工作人员安全。
  • 延迟扫描通过改善背景活度区清除、减少炎症过程显影,有助检出小而既往隐匿的恶性病灶。

核心结论

  • 全身PET从最初构想到如今全身及长轴视野(>1m)扫描仪已在全球商业化可用,其信号采集效率与高空间分辨率带来更高敏感性和病灶检出,增强多项常规PET/CT难以开展的临床应用。

研究设计与样本

  • 本文为综述,从全身PET的最初构想述及当前全身及长轴视野(>1m)扫描仪已在全球商业化可用的现状。

主要发现

  • 可缩短采集时间并保持诊断质量图像,受益于特定临床情形(如儿童患者)及存在随时间短暂摄取、采集时间微小差异可大幅影响图像判读的现有放射性示踪剂。
  • 可降低给药活度而对图像噪声影响极小,从而降低患者有效剂量、改善工作人员安全,并有助于短半衰期或长半衰期且剂量学特性不佳、此前在常规PET扫描仪上使用受限的放射性核素的物流安排。
  • 延迟扫描通过改善显著背景活度区域的清除及降低共存炎症过程的可见性,已显示可增加甚至小而既往隐匿恶性病灶的检出。
  • 图像质量因全身扫描仪更高空间分辨率和敏感性而改善,意味着对小结构有更好辨识,并对患者下游预后有临床意义。
  • 同步全身动态成像可测量放射性示踪剂完整时空分布、进行动力学建模并生成多参数图像,同时提供全身生理和生物学相关数据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 若放射科医生未按新技术重新校准判读,临床敏感性强烈影响可能增加假阳性发现数量。
  • 延迟扫描造成流程问题并为放射科医生引入新的判读问题。
  • 数据存储容量、更长的处理和重建时间问题也是局限,但可能通过重建算法和计算硬件的进步在不久的将来克服。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Total-body PET has come a long way from its first conception to today, with both total-body and long axial field of view (> 1m) scanners now being commercially available world-wide. The conspicuous signal collection efficiency gain, coupled with high spatial resolution, allows for higher sensitivity and improved lesion detection, enhancing several clinical applications not readily available on current conventional PET/CT scanners. This technology can provide (a) reduction in acquisition times with preservation of diagnostic quality images, benefitting specific clinical situations (i.e. pediatric patients) and the use of several existing radiotracers that present transient uptake over time and where small differences in acquisition time can greatly impact interpretation of images; (b) reduction in administered activity with minimal impact on image noise, thus reducing effective dose to the patient, improving staff safety, and helping with logistical concerns for short-lived radionuclides or long-lived radionuclides with poor dosimetry profiles that have had limited use on conventional PET scanners until now; (c) delayed scanning, that has shown to increase the detection of even small and previously occult malignant lesions by improved clearance in regions of significant background activity and by reduced visibility of coexisting inflammatory processes; (d) improvement in image quality, as a consequence of higher spatial resolution and sensitivity of total-body scanners, implying better appreciation of small structures and clinical implications with downstream prognostic consequences for patients; (e) simultaneous total-body dynamic imaging, that allows the measurement of full spatiotemporal distribution of radiotracers, kinetic modeling, and creation of multiparametric images, providing physiologic and biologically relevant data of the entire body at the same time. On the other hand, the higher physical and clinical sensitivity of total-body scanners bring along some limitations and challenges. The strong impact on clinical sensitivity potentially increases the number of false positive findings if the radiologist does not recalibrate interpretation considering the new technique. Delayed scanning causes logistical issues and introduces new interpretation questions for radiologists. Data storage capacity, longer processing and reconstruction time issues are other limitations, but they may be overcome in the near future by advancements in reconstruction algorithms and computing hardware.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ng QK, Triumbari EKA, Omidvari N, et al. Total-body PET/CT - First Clinical Experiences and Future Perspectives. Semin Nucl Med. 2022. PMID: 35272853. doi:10.1053/j.semnuclmed.2022.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。